This approach complementsnot replacestelehealth platforms like Mochi or Hers
Today we are announcing an industry-first: With Noom GLP-1 Rx we are providing both the medications and a pathway off the medications, said Chief Executive Officer of Noom, Geoff Cook
But recent and upcoming changes are starting to make these drugs more accessible for more Americans, including if you have Medicare
Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor ()
In the nearer term, disability income claimants with sustained weight loss could demonstrate an increase in functional capacity, including the ability to return to work
An observational analysis presented at ENDO 2026 found that physical activity declined after participants started GLP-1 treatment